Saturday, 31 October 2026European Markets

SELF STORAGE GROUP Stock Was Up By 14.15% Before The Weekend

Loading stream...

(VIANEWS) - The Market ended the session with SELF STORAGE GROUP (SSG.OL) jumping 14.15% to kr23.40 on Friday, following the last session's downward trend. Oslo Børs Benchmark Index_GI rose 0.33% to kr1,266.34, after two consecutive sessions in a row of losses, on what was a somewhat up trend trading session today.

SELF STORAGE GROUP's last close was kr20.50, 36.92% below its 52-week high of kr32.50.

About SELF STORAGE GROUP

Self Storage Group ASA engages in the rental of self-storage units to private individuals and businesses in Norway, Sweden, and Denmark. The company operates through OK Minilager, City Self-Storage, and Property segments. It operates climate controlled storage units and container based storage units. The company also retails storage ancillary goods, such as boxes, tapes, and other moving materials; distributes insurance products; and invests in, owns, and develops real estate properties. It operated various facilities in Scandinavia. The company was founded in 1993 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, SELF STORAGE GROUP has a trailing twelve months EPS of kr-0.66.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -3.89%.

Volume

Today's last reported volume for SELF STORAGE GROUP is 73245 which is 96.71% above its average volume of 37235.

Revenue Growth

Year-on-year quarterly revenue growth grew by 6.5%, now sitting on 411.7M for the twelve trailing months.

Yearly Top and Bottom Value

SELF STORAGE GROUP's stock is valued at kr23.40 at 22:31 EST, way below its 52-week high of kr32.50 and above its 52-week low of kr22.00.

More news about SELF STORAGE GROUP (SSG.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com